Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
LEGN: Legend Biotech Corporation Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
LEGN
The Story
LEGN
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+120.0% / yr
Operating margin
-11.9%
ROIC
-9.9%
Financially safe
Stretched
Debt / equity
0.40×
Interest coverage
-6.2×
Current ratio
2.13×
Legend Biotech Corporation
LEGN
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Legend Biotech Corporation
LEGN
NASDAQ
·
USD
·
Closed
$18.55
−2.62%
$18.55
−$0.50 (2.62%)
52W Range
10th
pctl
Volume
0.84×
avg
Mkt Cap
3.43B
USD
P/E
-13.6
TTM
Div Yield
–
ann
52W Range
10th
pctl
Volume
0.84×
avg
Market Cap
3.43B
USD
P/E Ratio
-13.6
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings